News Melanoma Recurrence and Spread Are Reduced by The Moderna, Merck Vaccine, Providing Fresh Hope for Treatment Can Big Tobacco’s Future Be Driven by Nicotine Pouches Instead of Cigarets? A Larger Quarterly Loss Is Caused by Hims & Hers Switching to Branded Obesity Medications Nikkei Claims That Sony and TSMC Will Invest $6.3 Billion To Jointly Produce Image Sensors Novavax Increases Its Yearly Revenue Prediction as Sluggish Vaccine Demand Is Mitigated by Licensing Bets Moderna’s First Mrna Flu Vaccination is Approved by The US FDA Pfizer Aims $2.5 Billion in Extra Cost Reductions After Exceeding Earnings Projections Eli Lilly Will Provide Early Access to A Next-Generation Obesity Medication Astrazeneca and Bristol Myers Squibb Discussed a $400 Billion Megadeal Health Officials Warn That Dropping American Humanitarian Funding Slows Down Ebola Epidemic Isolation Procedures In US Decongestant False Ad Litigation, “Maximum Strength” Must Contend by Pharmaceutical Companies and Retailers Medical Pioneers Bet on Miniature Drug Implants to Solve Long-Term Weight Loss Maintenance « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Next »
Melanoma Recurrence and Spread Are Reduced by The Moderna, Merck Vaccine, Providing Fresh Hope for Treatment
Novavax Increases Its Yearly Revenue Prediction as Sluggish Vaccine Demand Is Mitigated by Licensing Bets
Health Officials Warn That Dropping American Humanitarian Funding Slows Down Ebola Epidemic Isolation Procedures
In US Decongestant False Ad Litigation, “Maximum Strength” Must Contend by Pharmaceutical Companies and Retailers
